362703-48-8

Basic information

• Product Name: Ethyl 1-Boc-piperidine-2-carboxylate
• Synonyms: ETHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE;PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER 2-ETHYL ESTER;N-Boc- Piperidine-2-carboxylate;1-tert-butyl 2-ethyl piperidine-1,2-dicarboxylate;N-Boc-Piperidine-2-carboxylate or ethyl 1-Boc-piperidine-2-carboxylate;1,2-Piperidinedicarboxylic acid, 1-(1,1-diMethylethyl) 2-ethyl ester
• CAS NO: 362703-48-8
• Molecular Formula: C13H23NO4
• Molecular Weight: 257.33
• Product Categories: pharmacetical
• Mol File: 362703-48-8.mol

Chemical Properties

• Boiling Point: 323.9 °C at 760 mmHg
• Flash Point: 149.7 °C
• Appearance: /
• Density: 1.077 g/cm³
• Vapor Pressure: 0.000254mmHg at 25°C
• Refractive Index: 1.473
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -3.16±0.40(Predicted)
• CAS DataBase Reference: Ethyl 1-Boc-piperidine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 1-Boc-piperidine-2-carboxylate(362703-48-8)
• EPA Substance Registry System: Ethyl 1-Boc-piperidine-2-carboxylate(362703-48-8)

Safety Data

• Hazardous Substances Data: 362703-48-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 1-Boc-piperidine-2-carboxylate is used as a critical intermediate for the synthesis of complex molecules in drug production. Its role is essential in creating various pharmaceutical compounds, contributing to the development of new medications and therapies.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, Ethyl 1-Boc-piperidine-2-carboxylate is employed as a key component in the design and synthesis of novel drug candidates. Its structural properties allow for the exploration of new chemical pathways and the creation of potential therapeutic agents.
Used in Scientific Research:
Ethyl 1-Boc-piperidine-2-carboxylate is utilized in various scientific research applications, particularly in the study of organic chemistry and the development of new synthetic methods. Its versatility as a compound makes it a valuable tool for researchers in understanding and advancing the field of chemistry.

InChI:InChI=1/C13H23NO4/c1-5-17-11(15)10-8-6-7-9-14(10)12(16)18-13(2,3)4/h10H,5-9H2,1-4H3

Upstream product

• 3105-95-1 pipecolinic acid 
• 64-17-5 ethanol 
• 26250-84-0 (S)-(-)-1-(tert-butoxycarbonyl)-2-piperidinecarboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 15862-72-3 ethyl pipecolate 

Relevant articles and documents

BICYCLIC TRIAZOLE A4 INTEGRIN INHIBITORS

The compounds of the present invention are novel bicyclic triazole amino acid-derivatives useful as a4 integrin receptor antagonists. The invention is further directed to methods for treating integrin mediated disorders including, but not limited to, infl

The Baylis-Hillman reaction with chiral α-amino aldehydes under racemization-free conditions

The Baylis-Hillman reaction with chiral α-amino aldehydes has been revisited. The reaction carried out under the influence of ultrasound avoids the aldehyde racemization almost completely, providing useful chiral substrates which can be used as starting materials for the synthesis of natural products. To demonstrate the synthetic applicability of these adducts, the easy preparation of a bicyclic lactam with an indolizidinic skeleton was accomplished. Georg Thieme Verlag Stuttgart.

Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha

The present application describes novel β-amino acid derivatives of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, Ua, Xa, Ya, Za, R1, R2, R3

4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor

5-(4-Chlorophenyl)-3-(1-(4-chlorobenzyl)piperidin-4-yl)pyrazole (3) was identified from screening of the Merck sample collection as a human dopamine D4 (hD4) receptor ligand with moderate affinity (61 nM) and 4-fold selectivity over human D2 (hD2) recepto